Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality.
OBJECTIVE
This study set out to define the incidence, predictors, and mortality related to acute renal failure (ARF) and acute renal failure requiring dialysis (ARFD) after coronary intervention.


METHODS
Derivation-validation set methods were used in 1,826 consecutive patients undergoing coronary intervention with evaluation of baseline creatinine clearance (CrCl), diabetic status, contrast exposure, postprocedure creatinine, ARF, ARFD, in-hospital mortality, and long-term survival (derivation set). Multiple logistic regression was used to derive the prior probability of ARFD in a second set of 1,869 consecutive patients (validation set).


RESULTS
The incidence of ARF and ARFD was 144.6/1,000 and 7.7/1,000 cases respectively. The cutoff dose of contrast below which there was no ARFD was 100 mL. No patient with a CrCl > 47 mL/min developed ARFD. These thresholds were confirmed in the validation set. Multivariate analysis found CrCl [odds ratio (OR) = 0.83, 95% confidence interval (CI) 0.77 to 0.89, P <0.00001], diabetes (OR = 5.47, 95% CI 1.40 to 21.32, P = 0.01), and contrast dose (OR = 1.008, 95% CI 1.002 to 1.013, P = 0.01) to be independent predictors of ARFD. Patients in the validation set who underwent dialysis had a predicted prior probability of ARFD of between 0.07 and 0.73. The in-hospital mortality for those who developed ARFD was 35.7% and the 2-year survival was 18.8%.


CONCLUSIONS
The occurrence of ARFD after coronary intervention is rare (<1%) but is associated with high in-hospital mortality and poor long-term survival. Individual patient risk can be estimated from calculated CrCl, diabetic status, and expected contrast dose prior to a proposed coronary intervention.
McCullough
P A
PA
Department of Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA.
Wolyn
R
R
Rocher
L L
LL
Levin
R N
RN
O'Neill
W W
WW
D058186:Acute Kidney Injury / Q000097:blood / Q000209:etiology* / Q000401:mortality* / Q000503:physiopathology; D000368:Aged; D000369:Aged, 80 and over; D001806:Blood Urea Nitrogen; D003287:Contrast Media / Q000009:adverse effects; D003327:Coronary Disease / Q000097:blood / Q000401:mortality* / Q000503:physiopathology / Q000628:therapy*; D003404:Creatinine / Q000097:blood; D048909:Diabetes Complications; D005260:Female; D017052:Hospital Mortality; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D016017:Odds Ratio; D011237:Predictive Value of Tests; D012307:Risk Factors; D013318:Stroke Volume
D003287:Contrast Media; D003404:Creatinine